{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:26:34Z","timestamp":1787027194239,"version":"build-2736575974"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:p>\n                    There is a paucity of research, especially in the UK, that investigates individual differences in both medical and recreational cannabis users. A cross-sectional survey study design was used to assess recreational cannabis users and medical cannabis users currently living in the UK. Recreational cannabis users were invited to take part via social media. Medical cannabis users were recruited from Sapphire Medical Clinics, London, UK, which provides treatment with prescribed cannabis-based medicinal products. Demographic data and cannabis use frequency, as well as post-traumatic stress disorder symptoms (PCL-5), depression symptoms (Centre for Epidemiological Studies Depression Scale), trait and state anxiety (State-Trait Anxiety Inventory), and cannabis use motives [Comprehensive Marijuana Motives Questionnaire (CMMQ)] were collected. The Chi-square and independent-sample\n                    <jats:italic>t<\/jats:italic>\n                    -tests were used for the comparison of categorical variables and normally distributed continuous variables. Data were analyzed using analyses of variance (ANOVAs) and\n                    <jats:italic>t<\/jats:italic>\n                    -tests. Statistical significance was considered where the value of\n                    <jats:italic>p<\/jats:italic>\n                    was &amp;lt;0.05. The survey was completed by 161 participants. Medical cannabis users were older, consumed cannabis more often, had a higher \u201cSleep\u201d motive on the CMMQ, and had a higher prevalence in self-reporting current diagnoses of neurological problems, mood disorders, and anxiety disorders (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&amp;lt;\u20090.05). Recreational cannabis users had higher scores on several motives for use (e.g., \u201cEnjoyment,\u201d \u201cCoping,\u201d \u201cExperimentation,\u201d \u201cBoredom,\u201d and \u201cCelebration\u201d) and higher state anxiety scores (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&amp;lt;\u20090.05). The most common motives for cannabis use in both groups were \u201cEnjoyment,\u201d \u201cLow Risk,\u201d and \u201cSleep.\u201d There were no differences between groups in gender, \u201cLow-Risk\u201d motive, post-traumatic stress disorder symptoms, depression scores, trait anxiety scores, self-reported prevalence of substance use-related disorders, and past consumption of alcohol, tobacco, or caffeine (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&amp;gt;\u20090.05). The current study not only demonstrates a difference in age and motivations for cannabis consumption between recreational and medical cannabis users but also shows areas of potential overlap, including mental health outcomes, past substance use, and gender. These UK-specific findings indicate that recreational cannabis users experience higher state anxiety, highlighting the need for further evaluation of potential anxiogenic\/anxiolytic properties of cannabis. These findings demonstrate the importance of researching individual differences in cannabis users and hold significant implications for future research, clinical practice, and legislation.\n                  <\/jats:p>","DOI":"10.3389\/fpsyg.2023.1279123","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T09:52:37Z","timestamp":1704707557000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Cannabis use in the UK: a quantitative comparison of individual differences in medical and recreational cannabis users"],"prefix":"10.3389","volume":"14","author":[{"given":"Beata","family":"Ciesluk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Erridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael H.","family":"Sodergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy J.","family":"Troup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/02791072.2019.1643053","article-title":"Cannabis expectancies for sleep","volume":"51","author":"Altman","year":"2019","journal-title":"J. Psychoactive Drugs"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6511a1","article-title":"National estimates of marijuana use and related indicators\u2014National Survey on Drug Use and Health, United States, 2002\u20132014","volume":"65","author":"Azofeifa","year":"2016","journal-title":"Morb. Mortal. Wkly. Rep. Surveill. Summ."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.addbeh.2016.02.005","article-title":"Motives for marijuana use among heavy-using high school students: an analysis of structure and utility of the Comprehensive Marijuana Motives Questionnaire","volume":"57","author":"Blevins","year":"2016","journal-title":"Addict. Behav."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/jts.22059","article-title":"The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation","volume":"28","author":"Blevins","year":"2015","journal-title":"J. Trauma. Stress."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.addbeh.2017.08.001","article-title":"Utility of the comprehensive marijuana motives questionnaire among medical cannabis patients","volume":"76","author":"Bohnert","year":"2018","journal-title":"Addict. Behav."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/00952990.2013.821477","article-title":"Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users","volume":"40","author":"Bonn-Miller","year":"2014","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.addbeh.2006.03.018","article-title":"Marijuana use motives: concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers","volume":"32","author":"Bonn-Miller","year":"2007","journal-title":"Addict. Behav."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"106102","DOI":"10.1016\/j.addbeh.2019.106102","article-title":"Do marijuana use motives matter? Meta-analytic associations with marijuana use frequency and problems","volume":"99","author":"Bresin","year":"2019","journal-title":"Addict. Behav."},{"key":"ref9001","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.addbeh.2012.06.013","article-title":"Cannabis-related impairment and social anxiety: The roles of gender and cannabis use motives","volume":"37","author":"Buckner","year":"2012","journal-title":"Addict. Behav."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/CXA.0000000000000061","article-title":"Unhealthy cannabis use among recreational and medical cannabis users with type 1 diabetes","volume":"10","author":"Camsari","year":"2019","journal-title":"Can. J. Addict."},{"key":"ref9003","article-title":"The relationship between motivations for cannabis consumption and problematic use","volume":"33","author":"Casajuana-K\u00f6gel","year":"2021","journal-title":"Adicciones"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/ajad.12598","article-title":"Nonmedical versus medical marijuana use among three age groups of adults: associations with mental and physical health status","volume":"26","author":"Choi","year":"2017","journal-title":"Am. J. Addict."},{"key":"ref11","article-title":"Left behind: the scale of illegal cannabis use for medicinal intent in the UK","author":"Couch","year":"2020"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000236906","article-title":"Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders","volume":"42","author":"Dekker","year":"2009","journal-title":"Psychopathology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/17512433.2022.2020640","article-title":"UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder","volume":"15","author":"Ergisi","year":"2022","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s00181-018-1586-5","article-title":"Education, income and happiness: panel evidence for the UK","volume":"58","author":"FitzRoy","year":"2020","journal-title":"Empir. Econ."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jpsychires.2022.11.029","article-title":"Cannabis use in attention\u2013deficit\/hyperactivity disorder (ADHD): a scoping review","volume":"157","author":"Francisco","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/eip.12112","article-title":"Reasons for cannabis use among youths at ultra high risk for psychosis","volume":"9","author":"Gill","year":"2015","journal-title":"Early Interv. Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.copsyc.2021.03.005","article-title":"Trends over time in adult cannabis use: a review of recent findings","volume":"38","author":"Hasin","year":"2021","journal-title":"Curr. Opin. Psychol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.addbeh.2017.03.006","article-title":"Cannabis use patterns and motives: a comparison of younger, middle-aged, and older medical cannabis dispensary patients","volume":"72","author":"Haug","year":"2017","journal-title":"Addict. Behav."},{"key":"ref9006","article-title":"JASP (Version 0.18.1) [Computer software]","year":"2023"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/07448481.2019.1709474","article-title":"Anxiety and depression in a sample of UK college students: a study of prevalence, comorbidity, and quality of life","volume":"69","author":"Jenkins","year":"2021","journal-title":"J. Am. Coll. Heal."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-023-15883-6","article-title":"Trends of cannabis use and related harms before and after legalization for recreational purpose in a developing country in Asia","volume":"23","author":"Kalayasiri","year":"2023","journal-title":"BMC Public Health"},{"key":"ref21","first-page":"4","article-title":"De normalisering van cannabisgebruik","volume":"4","author":"Korf","year":"2006","journal-title":"Justiti\u00eble Verkenningen"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.15288\/jsad.2009.70.279","article-title":"Development and preliminary validation of a comprehensive marijuana motives questionnaire","volume":"70","author":"Lee","year":"2009","journal-title":"J. Stud. Alcohol Drugs"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.addbeh.2006.09.010","article-title":"Marijuana motives: young adults' reasons for using marijuana","volume":"32","author":"Lee","year":"2007","journal-title":"Addict. Behav."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.addbeh.2016.05.015","article-title":"Comparing adults who use cannabis medically with those who use recreationally: results from a national sample","volume":"61","author":"Lin","year":"2016","journal-title":"Addict. Behav."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1017\/S1474747211000448","article-title":"Financial literacy around the world: an overview","volume":"10","author":"Lusardi","year":"2011","journal-title":"J. Pens. Econom. Finan."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"100227","DOI":"10.1016\/J.LANEPE.2021.100227","article-title":"Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates","volume":"10","author":"Manthey","year":"2021","journal-title":"Lancet Region. Health Europe"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(21)00229-4","article-title":"The changing health needs of the UK population","volume":"397","author":"McKee","year":"2021","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1037\/adb0000210","article-title":"The mediating roles of coping, sleep, and anxiety motives in cannabis use and problems among returning veterans with PTSD and MDD","volume":"30","author":"Metrik","year":"2016","journal-title":"Psychol. Addict. Behav."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e0156614","DOI":"10.1371\/journal.pone.0156614","article-title":"\u201cI use weed for my ADHD\u201d: a qualitative analysis of online forum discussions on cannabis use and ADHD","volume":"11","author":"Mitchell","year":"2016","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/1360780419870814","article-title":"Medicinal cannabis users downplaying and shifting stigma: articulations of the \u2018natural\u2019, of what is\/is not a \u2018drug\u2019 and oppositions with \u2018chemical\u2019 substances","volume":"25","author":"Morris","year":"2020","journal-title":"Sociol. Res. Online"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e038687","DOI":"10.1136\/bmjopen-2020-038687","article-title":"So near yet so far: why won\u2019t the UK prescribe medical cannabis?","volume":"10","author":"Nutt","year":"2020","journal-title":"BMJ Open"},{"key":"ref32","article-title":"Drug misuse in England and Wales - Office for National Statistics","year":"2022"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/17512433.2023.2183841","article-title":"An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry","volume":"16","author":"Olsson","year":"2023","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"ref34","first-page":"201","article-title":"The normalization of marijuana use by adult Canadian users","volume":"2","author":"Osborne","year":"2007","journal-title":"International Journal of Crime, Criminal Justice, and Law"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/add.13282","article-title":"In the weeds: a baseline view of cannabis use among legalizing states and their neighbours","volume":"111","author":"Pacula","year":"2016","journal-title":"Addiction"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"27250","DOI":"10.4088\/PCC.13r01596","article-title":"A review of attention-deficit\/hyperactivity disorder in women and girls: uncovering this hidden diagnosis","volume":"16","author":"Quinn","year":"2014","journal-title":"Prim. Care Compan. CNS Disord."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl. Psychol. Meas."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00213-023-06399-3","article-title":"Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry","volume":"240","author":"Rifkin-Zybutz","year":"2023","journal-title":"Psychopharmacology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/ajad.12270","article-title":"Are medical marijuana users different from recreational users? The view from primary care","volume":"24","author":"Roy-Byrne","year":"2015","journal-title":"Am. J. Addict."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1207\/s15327752jpa4703_8","article-title":"Test-retest reliabilities of State-Trait Anxiety Inventory in a stressful social analogue situation","volume":"47","author":"Rule","year":"1983","journal-title":"J. Pers. Assess."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"114573","DOI":"10.1016\/j.psychres.2022.114573","article-title":"Medical cannabis use in Canada and its impact on anxiety and depression: a retrospective study","volume":"313","author":"Sachedina","year":"2022","journal-title":"Psychiatry Res."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/ijerph19042189","article-title":"Anxiety linked to COVID-19: a systematic review comparing anxiety rates in different populations","volume":"19","author":"Saeed","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1177\/0269881120926677","article-title":"Medical cannabis in the UK: from principle to practice","volume":"34","author":"Schlag","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/S0924-9338(10)71507-8","article-title":"PW01-111-prevalence of insomnia in general population","volume":"25","author":"Sepehrmanesh","year":"2010","journal-title":"Eur. Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02518-2","article-title":"Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties","volume":"18","author":"Sharpe","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1192\/bjo.2020.109","article-title":"Anxiety, depression, traumatic stress and COVID-19-related anxiety in the UK general population during the COVID-19 pandemic","volume":"6","author":"Shevlin","year":"","journal-title":"BJPsych Open"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/bjhp.12430","article-title":"COVID-19-related anxiety predicts somatic symptoms in the UK population","volume":"25","author":"Shevlin","year":"","journal-title":"Br. J. Health Psychol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/00914509211033921","article-title":"Where, when and with whom: cannabis use, settings and self-regulation rules","volume":"48","author":"Skliamis","year":"2021","journal-title":"Contemp. Drug Probl."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/10615809708249303","article-title":"Panic disorder and right-hemisphere reliance","volume":"10","author":"Smeets","year":"1997","journal-title":"Anxiety Stress Coping"},{"key":"ref50","volume-title":"Manual for the state-trait anxiety inventory (STAI)","author":"Spielberger","year":"1983"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.socscimed.2013.08.038","article-title":"Exploring substance use normalization among adolescents: a multilevel study in 35 countries","volume":"97","author":"Sznitman","year":"2013","journal-title":"Soc. Sci. Med."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"k3290","DOI":"10.1136\/bmj.k3290","article-title":"Medical cannabis will be available on prescription in UK from autumn","volume":"362","author":"Torjesen","year":"2018","journal-title":"BMJ"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.3390\/ijerph19127499","article-title":"Perceived stigma of patients undergoing treatment with cannabis-based medicinal products","volume":"19","author":"Troup","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"152188","DOI":"10.1016\/j.comppsych.2020.152188","article-title":"Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users","volume":"102","author":"Turna","year":"2020","journal-title":"Compr. Psychiatry"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"106642","DOI":"10.1016\/j.addbeh.2020.106642","article-title":"Cannabis use and sleep: expectations, outcomes, and the role of age","volume":"112","author":"Winiger","year":"2021","journal-title":"Addict. Behav."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1080\/10826084.2022.2102193","article-title":"Incidence and predictors of cannabis-related poisoning and mental and behavioral disorders among patients with medical cannabis authorization: a cohort study","volume":"57","author":"Zongo","year":"2022","journal-title":"Subst. Use Misuse"},{"key":"ref9007","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.addbeh.2007.06.010","article-title":"Marijuana use motives: A confirmatory test and evaluation among young adult marijuana users","volume":"32","author":"Zvolensky","year":"2007","journal-title":"Addict. Behav."}],"updated-by":[{"DOI":"10.3389\/fpsyg.2024.1368554","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000}}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2023.1279123\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T09:52:42Z","timestamp":1704707562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2023.1279123\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":61,"alternative-id":["10.3389\/fpsyg.2023.1279123"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2023.1279123","relation":{},"ISSN":["1664-1078"],"issn-type":[{"value":"1664-1078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"article-number":"1279123"}}